McGuinness, Myra B. https://orcid.org/0000-0002-5422-040X
Robman, Liubov
Hodgson, Lauren A. B.
Tran, Cammie
Woods, Robyn L.
Owen, Alice J.
McNeil, John J.
Makeyeva, Galina
Abhayaratna, Walter P.
Guymer, Robyn H. https://orcid.org/0000-0002-9441-4356
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1127060)
Department of Health | National Health and Medical Research Council (1051625)
Department of Health | National Health and Medical Research Council (1103013)
Department of Health | National Health and Medical Research Council (1173690)
Department of Health | National Health and Medical Research Council (471460)
Department of Health | National Health and Medical Research Council (1028368)
Department of Health | National Health and Medical Research Council (1173690)
Department of Health | National Health and Medical Research Council (1103013)
U.S. Department of Health & Human Services | National Institutes of Health (UO1AG029824)
U.S. Department of Health & Human Services | National Institutes of Health (U19AG062682)
U.S. Department of Health & Human Services | National Institutes of Health (R01EY026890)
U.S. Department of Health & Human Services | National Institutes of Health
Victorian Cancer Agency
Monash University
U.S. Department of Health & Human Services | National Institutes of Health
Jack Brockhoff Foundation
State Government of Victoria
Article History
Received: 10 March 2023
Revised: 6 September 2023
Accepted: 12 September 2023
First Online: 20 September 2023
Competing interests
: RHG is a consultant for Bayer, Novartis, Roche Genentech, Apellis, and Belite Bio. MBM is a consultant for Belite Bio.